Exciting Days at DCAT in New York!

Tiefenbacher Group - A group of seven smiling people in business attire take a selfie on a busy city street. A banner reads, "Tiefenbacher sends greetings from the DCAT." The TIEFENBACHER GROUP logo highlights this family-owned pharmaceutical company.

Our team sends greetings and impressions from the Big Apple!As we approach the final stretch of DCAT Week 2025 in New York, we reflect on an incredibly successful event so far! The Tiefenbacher Group team has had the privilege of engaging in insightful conversations, strengthening partnerships, and showcasing our latest innovations to make pharmaceuticals more […]

TIEFENBACHER AT DCAT 2022 IN NEW YORK CITY! – Thanks for Meeting us

Tiefenbacher Group - Blue "DCAT" logo in bold, uppercase letters with a registered trademark symbol in the upper right corner and a horizontal blue line beneath the letters, reflecting excellence in generic medicines manufacturing for finished dosage forms.

TIEFENBACHER GROUP AT DCAT 2022 – THANKS FOR MEETING US IN NEW YORK CITY!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 of the world´s most important pharma events – DCAT-Week in New York City – has just come to an end. It was four very successful and inspiring days for TIEFENBACHER GROUP presenting our latest product portfolio and innovations to our existing and […]